Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Efavirenz to Etravirine in HIV Patients with CNS Toxicity
NCT00792324Phase 3Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Jun 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etravirine in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Started Jun 2008; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00792324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792324.